RecruitingNCT06003036
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive iTBS, then Sham instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Deepak K. Sarpal, M.D.
- Condition
- Schizophrenia
RecruitingNCT04411225
This study is comparing Cannabidiol oral solution with placebo for people with Early Psychosis. Participants receive Cannabidiol oral solution or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 16 Years to 30 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
RecruitingNCT07309172
This observational study is following people with Schizophrenia Disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Denmark
- Sponsor
- Ole Köhler-Forsberg
- Condition
- Schizophrenia
RecruitingNCT07176468
This study is comparing Neuronavigation-guided individualized iTBS with Control group: ordinary drug treatment for people with Schizophrenia or Transcranial Magnetic Stimulation. Participants receive Neuronavigation-guided individualized iTBS or Control group: ordinary drug treatment and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Anhui Medical University
- Condition
- Schizophrenia
RecruitingNCT06502964
This study is looking at care and outcomes for people with Schizophrenia or Cognitive Impairment. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 21 Years to 55 Years
- Countries
- United States
- Sponsor
- Alto Neuroscience
- Condition
- Schizophrenia
RecruitingNCT06504290
This study is comparing VV119 Placebo (in healthy adult subjects) with placebo for people with Schizophrenia. Participants receive VV119 Placebo (in healthy adult subjects) or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Vigonvita Life Sciences
- Condition
- Schizophrenia
RecruitingNCT07061288
This study is looking at evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
RecruitingNCT05838573
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- China
- Sponsor
- Central South University
- Condition
- Schizophrenia
RecruitingNCT02670447
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT07060066
This study is looking at provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Depression
RecruitingNCT06640803
This study is looking at whether cognitive behavioural therapy can help people with Clinical High Risk for Psychosis or Ultra High Risk for Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherFrom 12 Years to 25 Years
- Countries
- United States
- Sponsor
- University of California, Davis
- Condition
- Schizophrenia
RecruitingNCT07242586
This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1, Schizotypal Disorder, or Post Traumatic Stress Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Denmark
- Sponsor
- Nikolai Albert
- Condition
- Schizophrenia
RecruitingNCT07003529
This study is looking at care and outcomes for people with Schizophrenia or Hallucinations, Auditory. Some participants may receive Control Group (SCZ+/AH-) instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Condition
- Schizophrenia
RecruitingNCT06597864
This study is looking at whether psychoeducation can help people with Psychosis or Schizophrenic. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 39 Years
- Countries
- Norway
- Sponsor
- Oslo University Hospital
- Condition
- Schizophrenia
RecruitingNCT06781801
This study is looking at whether Intervention can help people with psychosis. Participants take part in Intervention and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Sweden
- Sponsor
- Vastra Gotaland Region
- Condition
- Schizophrenia
RecruitingNCT06642675
This study is comparing Intermittent theta burst stimulation(iTBS) with control group: sham iTBS for people with Schizophrenia. Participants receive Intermittent theta burst stimulation(iTBS) or control group: sham iTBS and complete study visits and assessments.
SchizophreniaOtherUp to 60 Years
- Countries
- China
- Sponsor
- Central South University
- Condition
- Schizophrenia
RecruitingNCT07265180
This study is comparing Oxytocin with placebo for people with Schizophrenia Spectrum Disorders. Participants receive Oxytocin or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
- Condition
- Schizophrenia
RecruitingNCT07093671
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 14 Years to 30 Years
- Countries
- Switzerland
- Sponsor
- Marco Armando
- Condition
- Schizophrenia
RecruitingNCT07058389
This study is looking at whether a digital support tool can help people with schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT06581302
This study is looking at whether Magnetic seizure therapy by Magnetic stimulator can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- China
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Condition
- Schizophrenia
RecruitingNCT05131035
This study is looking at whether SCORES (Specific COgnitive Remediation with Support) can help people with Psychosis, Prodromal Schizophrenia, or Prodromal Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 14 Years to 20 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
RecruitingNCT05813457
This study is looking at whether a digital support tool can help people with Psychotic Episode. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 15 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT07196423
This study is looking at whether a digital support tool can help people with First Episode Psychosis or Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- University of Nottingham
- Condition
- Schizophrenia
RecruitingNCT07234708
This study is looking at whether Sentirnos Seguros can help people with Schizophrenia and Schizophrenia Spectrum Psychosis. Participants take part in Sentirnos Seguros and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Condition
- Schizophrenia
RecruitingNCT06634641
This study is looking at whether blood test can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Condition
- Schizophrenia